Environmental carbon monoxide level is associated with the level of high-sensitivity c-reactive protein in peritoneal dialysis patients

Medicine (United States)

Volumn 93, Issue 26, 2014, Pages

  Huang, Wen Hung ^a,b   Yen, Tzung Hai ^a,b   Chan, Ming Jen ^a   Su, Yi Jiun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE; CREATININE; INDICAN; NITROGEN; NITROGEN DIOXIDE; OZONE; SERUM ALBUMIN; SULFATE; SULFUR DIOXIDE; AIR POLLUTANT; BIOLOGICAL MARKER;

ADULT; AIR POLLUTANT; AIR QUALITY; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PARTICULATE MATTER; PERITONEAL DIALYSIS; AIR POLLUTION; ANALYSIS; BLOOD; ENVIRONMENTAL MONITORING; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TAIWAN;

ADULT; AIR POLLUTANTS; AIR POLLUTION; BIOMARKERS; C-REACTIVE PROTEIN; CARBON MONOXIDE; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84917706767     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000181     Document Type: Article

References (47)

1. Wang AY. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 2011;31:159-171.
2. Wang AY, Lam CW, Chan IH, et al. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers. Nephrol Dial Transplant. 2009;24:3826-3833.
3. Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14:1871-1879.
4. Wang AY, Lam CW, Chan IH, et al. Prognostic value of plasma myeloperoxidase in ESRD patients. Am J Kidney Dis. 2010;56:937-946.
5. Wang AY, Lam CW, Wang M, et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis. 2005;45:715-729.
6. Glorieux G, Cohen G, Jankowski J, et al. Platelet/leukocyte activation, inflammation, and uremia. Semin Dial. 2009;22:423-427.
7. Herbelin A, Urena P, Nguyen AT, et al. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991;39:954-960.
8. Yu M, Kim YJ, Kang DH. Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol. 2011;6:30-39.
9. Shimizu H, Hirose Y, Nishijima F, et al. ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration. Am J Physiol Cell Physiol. 2009;297:C389-396.
10. Meijers BK, Van Kerckhoven S, Verbeke K, et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis. 2009;54:891-901.
11. Dou L, Jourde-Chiche N, Faure V, et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost. 2007;5:1302-1308.
12. Chung SH, Heimburger O, Stenvinkel P, et al. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant. 2001;16:2240-2245.
13. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648-658.
14. Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant. 2002;17(Suppl 8):29-32.
15. Herzig KA, Purdie DM, Chang W, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2001;12:814-821.
16. Noh H, Lee SW, Kang SW, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1998;18:387-394.
17. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956-1960.
18. Rich DQ, Kipen HM, Huang W, et al. Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults. JAMA. 2012;307:2068-2078.
19. Bind MA, Baccarelli A, Zanobetti A, et al. Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort. Epidemiology. 2012;23:332-340.
20. Alexeeff SE, Coull BA, Gryparis A, et al. Medium-term exposure to traffic-related air pollution and markers of inflammation and endothelial function. Environ Health Perspect. 2011;119:481-486.
21. Samet JM. The Clean Air Act and health-a clearer view from 2011. N Engl J Med. 2011;365:198-201.
22. Dockery DW, Pope CA 3rd, Xu X, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329:1753-1759.
23. Dockery DW, Stone PH. Cardiovascular risks from fine particulate air pollution. N Engl J Med. 2007;356:511-513.
24. Mateen FJ, Brook RD. Air pollution as an emerging global risk factor for stroke. JAMA. 2011;305:1240-1241.
25. Tsai SS, Goggins WB, Chiu HF, Yang CY. Evidence for an association between air pollution and daily stroke admissions in Kaohsiung, Taiwan. Stroke. 2003;34:2612-2616.
26. Miller KA, Siscovick DS, Sheppard L, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356:447-458.
27. Davutoglu V, Zengin S, Sari I, et al. Chronic carbon monoxide exposure is associated with the increases in carotid intima-media thickness and C-reactive protein level. Tohoku J Exp Med. 2009;219:201-206.
28. Dou L, Bertrand E, Cerini C, et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 2004;65:442-451.
29. Huang WH, Hung CC, Yang CW, Huang JY. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients. Ther Apher Dial. 2012;16:361-367
30. Taiwan Air Quality Monitoring Network (TAQMN) operated by the Environmental Protection Administration (EPA). Air quality monitoring data of 2008 and 2009. http://taqm.epa.gov.tw/taqm/zh-tw/default.aspx. Accessed January 6, 2014
31. Peters A, Frohlich M, Doring A, et al. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J. 2001;22:1198-1204.
32. Zanobetti A, Schwartz J, Samoli E, et al. The temporal pattern of respiratory and heart disease mortality in response to air pollution. Environ Health Perspect. 2003;111:1188-1193.
33. Panasevich S, Leander K, Rosenlund M, et al. Associations of longand short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med. 2009;66:747-753.
34. Wang AY. Prognostic value of C-reactive protein for heart disease in dialysis patients. Curr Opin Investig Drugs. 2005;6:879-886.
35. Lai KN, Leung JC. Inflammation in peritoneal dialysis. Nephron Clin Pract. 2010;116:c11-c18.
36. Bergstrom J. Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease. Pol Arch Med Wewn. 2000;104:641-643.
37. Ducloux D, Bresson-Vautrin C, Kribs M, et al. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int. 2002;62:1417-1422.
38. Gan WQ, Davies HW, Koehoorn M, Brauer M. Association of longterm exposure to community noise and traffic-related air pollution with coronary heart disease mortality. Am J Epidemiol. 2012;175:898-906.
39. Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med. 2006;173:667-672.
40. Mitchell LA, Channell MM, Royer CM, et al. Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2010;299:L891-897.
41. Wunder C, Brock RW, Frantz S, et al. Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation. Crit Care Med. 2005;33:2323-2331.
42. Sass G, Soares MC, Yamashita K, et al. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology. 2003;38:909-918.
43. Astrup P, Kjeldsen K, Wanstrup J. Enhancing influence of carbon monoxide on the development of atheromatosis in cholesterol-fed rabbits. J Atheroscler Res. 1967;7:343-354.
44. Astrup P, Kjeldsen K, Wanstrup J. Effects of carbon monoxide exposure on the arterial walls. Ann N Y Acad Sci. 1970;174:294-300.
45. Smith CJ, Steichen TJ. The atherogenic potential of carbon monoxide. Atherosclerosis. 1993;99:137-149.
46. Stern FB, Halperin WE, Hornung RW, et al. Heart disease mortality among bridge and tunnel officers exposed to carbon monoxide. Am J Epidemiol. 1988;128:1276-1288.
47. Kleinman MT, Davidson DM, Vandagriff RB, et al. Effects of shortterm exposure to carbon monoxide in subjects with coronary artery disease. Arch Environ Health. 1989;44:361-369.